Nasdaq (NASDAQ) · Healthcare
Biotehnologie – Moderna (NASDAQ) MRNA
AvoidScore band: 10–20
Score is arithmetic here, not judgement. This ticker has non-positive earnings, so the Graham criteria cannot be computed and the low score reflects that arithmetic fact, not an analyst's opinion.
Vote for the next deep dive. This ticker has no full report yet. Subscribers vote on which candidate gets one next. Vote now →
Read it yourself
Step five of the method is the reader's: open the latest annual or quarterly report and read it before acting on anything here. A score is a summary, and a summary is not understanding.
Next report expected 2026-11-05.
Price, one year
Where the money goes
Last four reported quarters, 2025-09 → 2026-06, in USD. Filings data as gathered on 2026-09-08. Figures rounded to three significant digits.
Evaluation history
| Date | Verdict |
|---|---|
| 2026-05-17 | Avoid |
| 2026-09-06 | Avoid |
Want a report on this one?
No deep report has been written for this company yet. Subscribers get one full report a week by email and vote on which candidate is read next.